ID

34386

Descrizione

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver; ODM derived from: https://clinicaltrials.gov/show/NCT01501240

collegamento

https://clinicaltrials.gov/show/NCT01501240

Keywords

versioni (2)
  1. 17/01/19 17/01/19 -
  2. 14/05/19 14/05/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

17 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Liver Cirrhosis NCT01501240

Inglese

Eligibility Liver Cirrhosis NCT01501240

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descrizione

ID.1

Tipo di dati

boolean

patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descrizione

ID.2

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients under 20 years of age
Descrizione

ID.3

Tipo di dati

boolean

patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
Descrizione

ID.4

Tipo di dati

boolean

patients who underwent transarterial chemotherapy or radiofrequency ablation
Descrizione

ID.5

Tipo di dati

boolean

women who are pregnant, lactating or who are of childbearing potential
Descrizione

ID.6

Tipo di dati

boolean

patients with any physical or mental status than interferes with the signing of informed consent
Descrizione

ID.7

Tipo di dati

boolean

patients with a contraindication for mr
Descrizione

ID.8

Tipo di dati

boolean

patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
Descrizione

ID.9

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Eligibility Liver Cirrhosis NCT01501240

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
ID.2
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
patients under 20 years of age
boolean
ID.4
Item
patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
boolean
ID.5
Item
patients who underwent transarterial chemotherapy or radiofrequency ablation
boolean
ID.6
Item
women who are pregnant, lactating or who are of childbearing potential
boolean
ID.7
Item
patients with any physical or mental status than interferes with the signing of informed consent
boolean
ID.8
Item
patients with a contraindication for mr
boolean
ID.9
Item
patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial